Landscapes / Companies

Shanghai AbelZeta Ltd. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
1 in Phase 1
Next date
dnTGFβRII-armoured STEAP2-targeted autologous CAR T-Cell, Phase 1 trial completes
Drugs
4
in active trials · 5 in all
Trials
5 active
6 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
Gene therapy substances
AbelZeta
Phase 1/2 31 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 30 Apr 2030Phase 1/2 trial completes
—
Phase 1/2 —
—
Phase 1 31 Jan 2027Phase 1 trial completes

About

No active trial
Mesenchymal progenitor cells
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Shanghai AbelZeta Ltd.

Following is part of Solo: you see every change to Shanghai AbelZeta Ltd. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in